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1. INTRODUCTION 2. MATERIALS AND METHODS 
Prior exposure of thyroid tissue to thyrotropin 
(TSH) in vitro leads to desensitization, of the aden- 
ylate cyclase response to TSH stimulation [1-6]. 
Recently, it has been suggested that ADP-ribosyla- 
tion reactions may be involved in the TSH desensi- 
tization process [7,8]. Circumstantial support for 
this thesis was provided by the finding that TSH 
enhances ADP-ribosylation of acceptor proteins in 
isolated thyroid cells [9]. However, the nature of 
these proteins has not been established. One pro- 
tein of particular interest is the adenylate cyclase 
regulatory subunit (N, or G/F, protein), which is 
ADP-ribosylated during cholera toxin activation of 
adenylate cyclase (reviewed [10,11]. In [8] it was 
proposed that N protein ADP-ribosylation is im- 
portant in TSH desensitization i  the thyroid. 
However, epinephrine or p ostaglandin El desen- 
sitization in $49 mouse lymphoma cells is not asso- 
ciated with altered N protein function [12]. 
These studies were undertaken to examine, in 
the thyroid, whether N protein is specifically ADP- 
ribosylated by TSH. In addition, the functional ac- 
tivity of the N protein, as well as of the adenylate 
cyclase catalytic unit (C) was tested in membranes 
from thyroid cells desensitized to TSH. The data 
obtained suggest that N protein ADP-ribosylation 
is not responsible for TSH desensitization, and 
help localize the 'defect' in TSH desensitization to
TSH receptor (R) function, or to R -N  interaction. 
*To whom reprint requests should be addressed 
2.1. Cholera toxin-induced ADP-ribosylation of pu- 
rified thyroid plasma membranes 
Dog thyroid plasma membranes were prepared 
by discontinuous sucrose gradient sedimentation 
113,14]. The membranes (0.6 mg protein) were then 
treated for 30 min at 30°C with pre-activated 
cholera toxin (10 /~g/ml) in 100 /~M GTP and 
10/~M [32p]NAD+, in 200/zl final vol. [14]. Sam- 
ples (10-20 /4) were subjected to SDS-poly- 
acrylamide slab gel electrophoresis (7.5-15% gra- 
dient) [16]. Mr standards (10 000-70 000 Mr) were 
from Sigma Chemical Co. (catalogue no. MW- 
SDS-70). The gels were stained, dried and exposed 
to Kodak X-Omat XAR-5 film. 
2.2. TSH-induced ADP-ribosylation of dog thyroid 
cells 
The method in [9] was employed. The cells were 
diluted in ice-cold HME buffer (20 mM Hepes, 
2 mM MgC12, 1 mM EDTA, pH 7.4), then cen- 
trifuged for 10 rain at 1000 x g. The pellet was re- 
suspended in 3 ml HME buffer, supplemented 
with 1 mM ADP-ribose, 2 mM 3-isobutyl-l-meth- 
ylxanthine, 0.1 mM phenylmethylsulfonylfluoride. 
After homogenization with a Polytron the material 
was centrifuged (1000 x g for 15 min). The pellet 
was rehomogenized and re-centrifuged as above. 
The combined supernatants were centrifuged 
(30 000 x g for 30 min) and the pellet was sol- 
ubilized in a minimum volume (100-200 /~1) of 
SDS-containing buffer for slab gel electrophoresis 
[16]. 
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2.3. Assay of thyroid N protein function in $49 
Cyc(-) membranes 
Fresh dog thyroid slices (1 mm) were incubated 
(0.5 g/100 mm culture dish) for 5 h at 37°C in M- 
199 medium containing 10% fetal calf serum, with 
or without 50 mU/ml bovine TSH. After rinsing 5 
times in 100 vol. ice-cold phosphate-buffered sa-
line (pH 7.4) the tissue was homogenized with a 
Polytron in 5 ml HME buffer. The 500 X g (15 
rain) supernatant was centrifuged at 8000 x g for 
15 rain. The pellet was resuspended in 10 mM Tris, 
0.1 mM EDTA, 1 mM 2-mercaptoethanol (pH 7.5) 
(TEM buffer) [17] and recentrifuged at 8000 x g 
for 15 min. 
This crude thyroid membrane preparation was 
extracted with Lubrol PX [17]. N-protein extract 
(10 t~l) was incubated for 20 min at 30°C with 
30/.tl 'assembly cocktail' [17] containing 15-30 ~g 
$49 Cyc(-) plasma membranes (kindly provided 
by Dr. Henry Bourne, University of California, 
San Francisco). [a-32p]ATP was then added (10 ~1) 
to a final conc. 0.4 raM. Adenylate cyclase activity 
was assayed (30 min at 300C) as in [18], in the 
presence of different activators (included in the as- 
sembly cocktail), as indicated in the text. Protein 
was measured as in [30]. Lubrol PX (0.2%) was 
chosen on the basis of preliminary experiments 
(not shown). The addition of increasing amounts 
of thyroid membrane Lubrol extract, up to - 4 ~g/ 
tube, produced a linear increase in Cyc(-)  aden- 
ylate cyclase activity. 
2.4. Thyroid cell cAMP 
Thyroid ceils were prepared as in [20]. Cellular 
cAMP was measured by radioimmunoassay [1,21]. 
2.5. Materials 
Purchases were made from the following 
sources: Lubrol PX (L-3753) and phenylmethylsul- 
fonylfluoride, from Sigma Chemical Co. (St Louis 
MO); bovine TSH (Thytropar) from Armour 
Pharmaceutical Co. (Phoenix AZ); forscolin (for- 
skolin) from Calbiochem-Behring Corp. (La Jolla 
CA); sources of other compounds have been re- 
ported [9]. 
3. RESULTS 
3.1. A DP-ribose protein(s) in thyroid cells 
To identify the N protein highly purified thyroid 
plasma membranes were treated with cholera toxin 
in the presence of [32p]NAD+. Electrophoresis of
the membranes revealed 2 radiolabeled proteins; a 
primary acceptor protein of -43  000 M r, and a 
lesser one of -47  000 Mr (fig.lA). The former pro- 
tein is presumably the N protein of 42 000 Mr de- 
scribed in other tissues [10]. The latter protein may 
correspond to the 52 000 Mr component in $49 
cells [ 15]. 
TSH stimulation of dispersed, permeabilized 
thyroid cells increases [32p]ADP-ribose incorpora- 
tion from [32p]NAD+ by 50-150% [9]. Electro- 
phoresis of the particulate fraction f ADP-ribo- 
sylated thyroid ceils revealed numerous ADP-ribo- 
sylated proteins interspersed in a background 
smear of ADP-ribosylated material (fig.lB). Most 
ADP-ribosylation occurred in unidentified pro- 
teins of very low Mr and in one protein of 96 000 
M r. TSH stimulated ADP-ribosylation of all pro- 
teins, in particular one of 59 000 Mr, which is un- 
identified. Basal and TSH-induced ADP-ribosyla- 
tion was observed in a protein of 41 000-43 000 
M r, presumably the N protein. However, this rep- 
Table 1 
TSH desensitization is not associated with a reduced 




2nd Incubation Thyroid cell cAMP 
(0.5 h) 
Additives (pmol/10 6 cells) 
- -  - -  8 .0  _ 1 .3  a 
TSH b - 29.7 + 1.4 
- TSH b 361 _ 14.5 
TSH b TSH b 148 ± 6.0 
- Forskolin c 1805 + 164 
TSH b Forskolin c 2076 + 87 
aMean +_ SD of values obtained in triplicate dishes of 
cells 
hi0 mU TSH/ml; c 100/tM forskolin 
Dog thyroid cells were subcultured in 35 mm diam. 
dishes (2 × 105 cells/dish). The first incubation was in 
M-199 medium containing 10% fetal calf-serum (water- 
saturated incubator, 37°C, 5% CO2). The second incuba- 
tion was in L-15 medium containing 0.5 mM 3-isobutyl- 
l-methylxanthine, 20 mM Hepes (pH 7.4) (water-bath, 
37°C, room air). Cellular cAMP was determined at the 
end of the second incubation 
24 
FEBS LETTERS Volume 146, number 1 September 1982 
- -  72K  
- -  59K  
- -  41K  
- -  301(  
- -  ~ K  
- -  2 ~  ¸ 
A 
Fig.l. (A) SDS-Polyacrylamide slab gel electrophoresis of highly-purified thyroid plasma membranes subjected to 
cholera toxin-induced ADP-ribosylation as in section 2. (B) Electrophoretic profile of ADP-ribosylated dog thyroid cell 
particulate proteins. Freshly dispersed og thyroid cells were permeabilized and incubated in [32p]NAD+ in the ab- 
sence or presence of 50 mU TSH/ml as in section 2. The 30 000 × g particulate fraction was solubilized and subjected to 
SDS-polyacrylamide g lelectrophoresis. 
resented < 1% of total ADP-ribosylated material 
in the thyroid cells. ADP-ribosylation of the super- 
natant fraction was very low and adequate auto- 
radiographs could not be obtained (not shown). 
3.2. Reconstitution fS49 Cyc(-) adenylate cyclase 
with thyroid membrane extract 
$49 Cyc(-)  cell adenylate cyclase, deficient in N 
protein, is unresponsive to isoproterenol and fluo- 
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Fig.2. Reconstitution f $49 Cyc(-) adenylate cyclase 
activity using a detergent extract of dog thyroid plasma 
membranes. Dog thyroid slices were preincubated in
control medium or in medium containing TSH (50 mU/ 
ml) for 5 h. A crude plasma embrane fraction from 
this tissue was extracted with Lubrol PX, and this extract 
was used to reconstitute N protein deficient Cyc(-) ade- 
nylate cyclase, as in section 2. Cyc(-) membranes (15 
30 /~g) were stimulated for 30 min at 30°C in either 
10 4 M isoproterenol, 10 4 M isoproterenol + 10-4 M 
Gpp(NH)p, or 10 mM NaF. For each of these stimula- 
tors, the indicated amount of thyroid membrane extract, 
from control or TSH-desensitized tissue, was used to 
reconstitute Cyc(-) activity. Each point represents the 
mean +_ SD of triplicate determinations. 
ride stimulation [10]. Detergent extracts of plasma 
membranes from a variety of tissue can be used to 
reconstitute Cyc(-) adenylate cyclase, and to re- 
store its response to isoproterenol (reviewed [10]). 
Thyroid plasma membrane xtract was also found 
to be capable of restoring responsiveness to the 
Cyc(-) system (fig.2). Most importantly, thyroid 
membrane N protein extract from TSH-pretreated 
(desensitized) cells, and from control cells, had 
similar activity. 
3.3. Catalytic unit function in TSH-desensitized 
thyroid cells 
Forskolin is a diterpene compound that activates 
the adenylate cyclase catalytic unit in intact cells 
[23]. Forskolin stimulation of cAMP content was 
the same in control and in TSH-desensitized thy- 
roid cell monolayers (table 1). 
4. DISCUSSION 
Our data indicate that the physiological signifi- 
cance of TSH-induced ADP-ribosylation of cellu- 
lar acceptor proteins is much more complex than a 
simple alteration of the adenylate cyclase regulat- 
ory protein (N, or G/F). A wide variety of proteins 
are ADP-ribosylated. Although N appears to be 
ADP-ribosylated in thyroid cells, this represents 
only a quantitatively minor component in the 
overall spectrum of ADP-ribosylated proteins of as 
yet unknown function. Most ADP-ribosylation in 
the thyroid appears to occur in particulate rather 
than in soluble proteins. Our finding of a large 
number of ADP-ribosylated cellular proteins is 
consistent with data obtained in other systems; 
e.g., insulin and epidermal growth factor-induced 
ADP-ribosylation of BALBc/3T3 fibroblasts [24] 
and ADP-ribosylation of turkey erythrocyte pro- 
teins by a cytosolic ADP-ribosyltransferase [25]. In 
contrast, with isoproterenol stimulation of RL-PR- 
C hepatocyte membranes, the only ADP-ribose ac- 
ceptor is a 55 000 Mr protein [26]. Although or- 
mone activation of adenylate cyclase may involve 
ADP-ribosylation of the N protein [8,26], our data 
do not support (or refute) this thesis. 
In [8] it was suggested that TSH desensitization 
relates to an ADP-ribosylation-mediated alteration 
in N protein activity. However, these data ob- 
tained using the $49 Cyc(-) reconstitution assay 
supports previous, indirect evidence that both N 
and C are functionally normal [5]. Data regarding 
the functional activity of the TSH receptor in TSH 
desensitization i  cultured cells are conflicting 
[5,6]. These data are consistent with those regard- 
ing epinephrine and prostaglandin El desensitiza- 
tion in S-49 lymphoma cells [12]. In addition for- 
skolin, an activator of C (either directly, or via an 
as yet unidentified regulatory protein), is equally 
effective in control and TSH-desensitized cells. 
Our evidence supports the concept of an 'un- 
coupling' of adenylate cyclase components in the 
desensitization process. In the thyroid this may be 
between R and N, as suggested in [2]. 
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